REVANCE THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.77 USD | -0.66% |
|
+14.59% | -57.11% |
| 04-26 | AbbVie raises annual profit forecast on strong Skyrizi sales | RE |
| 04-12 | Revance Therapeutics, Inc. to Present New DAXXIFY Data at the American Academy of Neurology 2024 Annual Meeting | CI |
Quotes 5-day view
Delayed Quote Nasdaq| 29/04/2024 | 30/04/2024 | 01/05/2024 | 02/05/2024 | |
|---|---|---|---|---|
| Last | 3.69 $ | 3.61 $ | 3.795 $ | 3.77 $ |
| Volume | 3 223 918 | 2 111 319 | 1 960 600 | 1 256 213 |
| Change | +8.53% | -2.17% | +5.12% | -0.66% |
| Opening | 3.45 | 3.63 | 3.75 | 3.91 |
| High | 3.77 | 3.79 | 4.06 | 3.99 |
| Low | 3.41 | 3.51 | 3.65 | 3.66 |
Performance
| 1 day | -0.66% | ||
| 1 week | +14.59% | ||
| Current month | +4.43% | ||
| 1 month | -16.41% | ||
| 3 months | -29.80% | ||
| 6 months | -55.33% | ||
| Current year | -57.11% | ||
| 1 year | -88.62% | ||
| 3 years | -87.05% | ||
| 5 years | -71.63% | ||
| 10 years | -88.52% |
Volumes
marketsDaily volume
1 256 213
Estimated daily volume
1 256 213
Avg. Volume 20 sessions
2 026 739
Daily volume ratio
0.62
Avg. Volume 20 sessions USD
7 640 806.03
Record volume 1
17 254 810
Record volume 2
13 135 267
Record volume 3
11 658 040
Capital turnover ratio
0.02
Float rotation
0.02
Basic data
Capitalization (USD)
395 498 255
Net sales (USD)
234 040 000
Number of employees
597
Sales / Employee (USD)
392 027
Free-Float
91.53 %
Free-Float capitalization (USD)
361 988 534
Average Daily Capital Traded
1.93%
Highs and lows
1 week
3.41
4.06
1 month
3.214.94
Current year
3.219.75
1 year
3.2137.98
3 years
3.2137.98
5 years
3.2137.98
10 years
3.2142.41
Indicators
Moving average 5 days
3.65
Moving average 20 days
3.94
Moving average 50 days
4.89
Moving average 100 days
5.80
Price spread / (MMA5)
-3.10%
Price spread / (MMA20)
+4.38%
Price spread / (MMA50)
+29.68%
Price spread / (MMA100)
+53.90%
STIM
RSI 9 days
46.78
RSI 14 days
41.40
Sector Comparison - Biopharmaceuticals
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| -0.66% | +14.59% | -57.11% | -88.62% | 395M | ||
| +0.22% | -1.07% | -3.72% | -8.74% | 86.16B | ||
| +0.77% | -2.62% | +2.76% | -.--% | 40.17B | ||
| -1.21% | +5.46% | -17.49% | -30.97% | 31.47B | ||
| -2.17% | +0.08% | +54.44% | +44.68% | 25.24B | ||
| +0.52% | +1.94% | -13.13% | -10.72% | 15.82B | ||
| -0.32% | +2.61% | -9.12% | -8.90% | 11.96B | ||
| +0.28% | +3.73% | -15.45% | -24.11% | 11.89B | ||
| -1.68% | -12.71% | -42.56% | -35.29% | 11.61B | ||
| -1.89% | +4.09% | +4.87% | +11.29% | 8.84B | ||
| +9.41% | +15.77% | -2.11% | +15.13% | 7.93B | ||
| -3.29% | -2.48% | -1.79% | +11.19% | 7.68B | ||
| +0.23% | +6.37% | +79.59% | +306.67% | 6.77B | ||
| -0.28% | +1.70% | -10.25% | +9.28% | 6.59B | ||
| +1.48% | -0.59% | -7.01% | +7.35% | 6.55B | ||
| +3.13% | -0.92% | -20.66% | -42.88% | 5.59B | ||
| Average | +0.28% | +2.76% | -3.67% | +9.71% | ||
| Weighted average by Cap. | +0.02% | +1.16% | -0.28% | +2.27% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Last transactions
6ee04755add074aa36ee7a75a09a238a.P0cc8nlhNCanjHuZBVsn83vdWwMSD2GAvhLQ36bqz8s.Cn50oSBZc1zStTLgag0QoTmzL2dBOBTS0EH9lMWw9psHMyiKHAdWfpX-GA
| Date | Price | Volume | Daily volume |
|---|---|---|---|
| 21:00:00 | 3.77 | 131,598 | 1,135,688 |
| 20:59:59 | 3.775 | 200 | 1,004,090 |
| 20:59:55 | 3.775 | 146 | 1,003,890 |
| 20:59:54 | 3.78 | 100 | 1,003,744 |
| 20:59:54 | 3.77 | 100 | 1,003,644 |
| 20:59:54 | 3.77 | 100 | 1,003,544 |
| 20:59:54 | 3.77 | 400 | 1,003,444 |
| 20:59:54 | 3.77 | 1,500 | 1,003,044 |
| 20:59:54 | 3.77 | 300 | 1,001,544 |
| 20:59:54 | 3.77 | 100 | 1,001,244 |
Monthly variations
Annual change
| 2024 | -57.11% | ||
| 2023 | -52.38% | ||
| 2022 | +13.11% | ||
| 2021 | -42.41% | ||
| 2020 | +74.61% | ||
| 2019 | -19.37% | ||
| 2018 | -43.69% | ||
| 2017 | +72.71% | ||
| 2016 | -39.40% | ||
| 2015 | +101.65% | ||
| 2014 | -36.91% |
- Stock Market
- Equities
- RVNC Stock
- Quotes Revance Therapeutics, Inc.
